sophie CAZALBOU

Dr. sophie CAZALBOU


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2018 in SN Applied Sciences
Verified
Journal Article
Open access
PDF file
IMInnocent Macha
Innocent Macha
IKIpek Karacan
Ipek Karacan
Besim Ben-NissanBesim Ben-Nissan
Besim Ben-Nissan
SCsophie CAZALBOU
sophie CAZALBOU
WMWolfgang H. Müller
Wolfgang H. Müller
While one of the major clinical and scientific challenges in the management of implant-related infections and post-operative complications after surgery is the application of new techniques, a new approach is pertinent in the design of medical implants to reduce bacterial infections. We have designed and tested antibiotic-containing biocomposite thin films of polylactic acid (PLA), and coralline-derived hydroxyapatite (HAp) as controlled drug delivery systems for the treatment of dental, orthopaedic and neural implant-related post-operative infections. These films can be applied to complicated designs of dental, miniaturized neural devices, cochlear or total hip replacement (THR) implants by spray or dip-coating techniques. Current results reveal that the devices could release antibiotic in a controlled manner to prevent significantly bacterial growth and biofilm production. Hydroxyapatite within the composites controls the release rate and also supplies minerals, such as calcium Ca2+ and phosphate PO42− ions, which are essential minerals for bone tissue regeneration. It is concluded from the physical, mechanical and biological properties that these coatings and devices could easily be utilized in a wide range of biomedical applications.

21 January 2016 in Journal of Materials Science
Verified
Journal Article
Closed access
PDF file
SJSylvaine Jacquart
Sylvaine Jacquart
DPDominique Poquillon
Dominique Poquillon
GDGérard Dechambre
Gérard Dechambre
SCsophie CAZALBOU
sophie CAZALBOU
CRChristian Rey
Christian Rey
CCChristèle Combes
Christèle Combes

5 September 2023 in Bioengineering
Verified
Journal Article
Open access
PDF file
AMAndrea Marfoglia
Andrea Marfoglia
FTFahd Tibourtine
Fahd Tibourtine
LPLudovic Pilloux
Ludovic Pilloux
SCsophie CAZALBOU
sophie CAZALBOU
Hydrogels (gels) are attractive tools for tissue engineering and regenerative medicine due to their potential for drug delivery and ECM-like composition. In this study, we use rheology to characterize GelMA/alginate gels loaded with human platelet lysate (PL). We then characterize these gels from a physicochemical perspective and evaluate their ability to transport PL proteins, their pore size, and their rate of degradation. Finally, their biocompatibility is evaluated. We describe how alginate changes the mechanical behavior of the gels from elastic to viscoelastic after ionic (calcium-mediated) crosslinking. In addition, we report the release of ~90% of PL proteins from the gels and relate it to the degradation profile of the gels. Finally, we evaluated the biocompatibility of the gels. Thus, the developed gels represent attractive substrates for both cell studies and as bioactive materials.

19 June 2023 in Bioengineering
Verified
Journal Article
Open access
PDF file
HKHyoung-Jun Kim
Hyoung-Jun Kim
Prescillia LagarriguePrescillia Lagarrigue
Prescillia Lagarrigue
JOJae-Min Oh
Jae-Min Oh
JSJérémy Soulié
Jérémy Soulié
FSFabrice Salles
Fabrice Salles
Christophe DrouetChristophe Drouet
Christophe Drouet
Layered Double Hydroxides (LDHs) are inorganic compounds of relevance to various domains, where their surface reactivity and/or intercalation capacities can be advantageously exploited for the retention/release of ionic and molecular species. In this study, we have explored specifically the applicability in the field of bone regeneration of one LDH composition, denoted “MgFeCO3”, of which components are already present in vivo, so as to convey a biocompatibility character. The propensity to be used as a bone substitute depends, however, on their ability to allow the fabrication of 3D constructs able to be implanted in bone sites. In this work, we display two appealing approaches for the processing of MgFeCO3 LDH particles to prepare (i) porous 3D scaffolds by freeze-casting, involving an alginate biopolymeric matrix, and (ii) pure MgFeCO3 LDH monoliths by Spark Plasma Sintering (SPS) at low temperature. We then explored the capacity of such LDH particles or monoliths to interact quantitatively with molecular moieties/drugs in view of their local release. The experimental data were complemented by computational chemistry calculations (Monte Carlo) to examine in more detail the mineral–organic interactions at play. Finally, preliminary in vitro tests on osteoblastic MG63 cells confirmed the high biocompatible character of this LDH composition. It was confirmed that (i) thermodynamically metastable LDH could be successfully consolidated into a monolith through SPS, (ii) the LDH particles could be incorporated into a polymer matrix through freeze casting, and (iii) the LDH in the consolidated monolith could incorporate and release drug molecules in a controlled manner. In other words, our results indicate that the MgFeCO3 LDH (pyroaurite structure) may be seen as a new promising compound for the setup of bone substitute biomaterials with tailorable drug delivery capacity, including for personalized medicine.

15 March 2019 in Journal of the Australian Ceramic Society
Verified
Journal Article
Closed access
PDF file
SBS. A. S Bonou
S. A. S Bonou
ESE. Sagbo
E. Sagbo
CAC. Aubry
C. Aubry
CCC. Charvillat
C. Charvillat
BBB. Ben-Nissan
B. Ben-Nissan
SCsophie CAZALBOU
sophie CAZALBOU

30 October 2020 in Journal of Materials Science
Verified
Journal Article
Closed access
PDF file
CAC. Aubry
C. Aubry
SCS. Camy
S. Camy
CCC. Combes
C. Combes
OMO. Marsan
O. Marsan
Thibault CanceillThibault Canceill
Thibault Canceill
SCsophie CAZALBOU
sophie CAZALBOU